Crossmark

Patients’ and clinicians’ preferences for adjuvant chemotherapy in endometrial cancer: an ANZGOG substudy of the PORTEC-3 intergroup randomised trial

Crossref DOI link: https://doi.org/10.1038/bjc.2016.323

Published Online: 2016-10-20

Published Print: 2016-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

,

Blinman, Prunella

Mileshkin, Linda

Khaw, Pearly

Goss, Geraldine

Johnson, Carol

Capp, Anne

Brooks, Susan

Wain, Gerard

Kolodziej, Ilka

Veillard, Anne-Sophie

O'Connell, Rachel

Creutzberg, Carien L

Stockler, Martin R
License Information

Text and Data Mining valid from 2016-10-20
More Information

Article History

Received: 5 April 2016

Revised: 18 August 2016

Accepted: 10 September 2016

First Online: 20 October 2016

Competing interests

: The authors declare no conflict of interest.